Earum Pharmaceuticals Rights Issue Details 2022, Record Date, Entitlement
Last updated August 22, 2026
This IPO News reference page covers “Earum Pharmaceuticals Rights Issue Details 2022, Record Date, Entitlement”. The page is organized around earum pharmaceuticals limited rights issue details, earum pharmaceuticals limited rights issue dates, earum pharmaceuticals limited rights issue objective, company financials, about company. IPO News presents the structured facts and tables in its own layout and wording.
Topics Covered
- Earum Pharmaceuticals Limited Rights Issue Details
- Earum Pharmaceuticals Limited Rights Issue Dates
- Earum Pharmaceuticals Limited Rights Issue Objective
- Company Financials
- About Company
- Company Address
- Earum Pharmaceuticals Lead Manager
- Earum Pharmaceuticals RI Registrar
Key Facts
- India's trusted financial research platform since 2015. Live IPO GMP, subscription data, allotment status, Rights Issues, NCDs and unbiased stock broker reviews.
- Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call.
Data Tables
| Issue Size (Shares) | 24.67 Cr Shares |
|---|---|
| Issue Size (Amount) | ₹49.34 Cr |
| Face Value | ₹2 Per Share |
| Issue Price | ₹2 per share |
| Record Date | 10th Apr 2023 |
| Listing At | BSE |
| BSE Code | 542724 |
| Letter of Offer | |
| Online Application (Registrar & Transfer Agent) | |
| Entitlement | 4 Equity Shares for every 1 Equity Shares held on the Record Date |
| Terms of payment | Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call. |
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
|---|---|---|---|---|
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
| Amount in ₹ Crore |
Source record: View original public source ↗